Williams Timothy

Williams Timothy is listed in filings as SVP & General Counsel at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Apr 14, 2026, including sale activity. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA) and Geron Corporation (GERN). The current snapshot covers public activity from Feb 20, 2025 to Apr 14, 2026. Reported amounts are shown as $128.2K to $4.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.